|
A Study of Lobucavir in Patients with AIDS Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about A Study of Lobucavir in Patients with AIDS conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Study of Lobucavir in Patients with AIDS Clinical research trials and A Study of Lobucavir in Patients with AIDS healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as A Study of Lobucavir in Patients with AIDS. A Study of Lobucavir in Patients with AIDS Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Study of Lobucavir in Patients with AIDS clinical trial. Subjects frequently obtain the most expert healthcare possible for their A Study of Lobucavir in Patients with AIDS condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Lobucavir in Patients with AIDS  A Study of Lobucavir in Patients with AIDS
A Study of Lobucavir in Patients with AIDS
For Condition: Cytomegalovirus Infections,HIV Infections
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.
Details: Patients receive 1 of 2 doses of lobucavir for 28 days, with 2 weeks of follow-up. Weekly clinic visits are required.
Eligibility:
Study Type: Interventional, Treatment, Dose Comparison, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: - Aerosolized pentamidine. - TMP / SMX. - Isoniazid. - Dapsone. - Fluconazole. - Ketoconazole. - Rifabutin. - Fluoxetine HCl. - Acetaminophen. - Antacids. - Metamucil. - Multivitamins. - Other drugs with approval from sponsor. Patients must have: - AIDS. - CD4 count < 200 cells/mm3. - Cytomegalovirus ( CMV ) viruria and virosemenia. - No evidence of intraocular CMV. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Acute or chronic cardiovascular, pulmonary, renal, hepatic, pancreatic, hematologic, endocrine, neurological, or other unstable illness. - Inability to take oral medication. - Allergy to nucleoside analogs. - Diarrheal illness. - Poor venous access. - Positive test for drugs of abuse. - Any other condition that would render patient unsuitable for study. Patients with the following prior conditions are excluded: - History of pancreatitis. - Recent diarrheal illness. - History of weight loss. - Acute serious illness within 4 weeks prior to study entry. Prior Medication: Excluded within 4 weeks prior to study entry: - Erythropoietin. - Any agent with anti-CMV activity. - Other investigational agents. Prior Treatment: Excluded within 4 weeks prior to study entry: - Surgery. - Blood transfusion. Drug abuse.
Total Enrollment: 30
Location and Contact Information:
Mount Zion Med Ctr / UCSF
San Francisco, California, 94115
United States
San Francisco Veterans Adm Med Cntr
San Francisco, California, 94121
United States
Univ of Minnesota
Minneapolis, Minnesota, 55455
United States
Additional Information:
Study ID Numbers: 248A; AI459-007
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002352
Other Hiv Infections Studies:
1. The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used with and without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
2. The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used with or without Clofazimine in the Treatment of MAC in Patients with AIDS
3. Problems Associated with the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
4. A Study to Monitor Patients with Primary or Early HIV Infection
5. Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
Related Studies:
Other HIV Infections Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials
A Study of Lobucavir in Patients with AIDS
|
|
|
|
|
|
|
|
